World Health Organization Methodology to Prioritize Emerging Infectious Diseases in Need of Research and Development.
Emerg Infect Dis
; 24(9)2018 09.
Article
em En
| MEDLINE
| ID: mdl-30124424
ABSTRACT
The World Health Organization R&D Blueprint aims to accelerate the availability of medical technologies during epidemics by focusing on a list of prioritized emerging diseases for which medical countermeasures are insufficient or nonexistent. The prioritization process has 3 components a Delphi process to narrow down a list of potential priority diseases, a multicriteria decision analysis to rank the short list of diseases, and a final Delphi round to arrive at a final list of 10 diseases. A group of international experts applied this process in January 2017, resulting in a list of 10 priority diseases. The robustness of the list was tested by performing a sensitivity analysis. The new process corrected major shortcomings in the pre-R&D Blueprint approach to disease prioritization and increased confidence in the results.
Palavras-chave
Crimean-Congo hemorrhagic fever; Ebola virus; Lassa virus; Marburg virus infection; Middle East respiratory syndrome coronavirus; Nipah virus; R&D Blueprint; Rift Valley fever; South American hemorrhagic fever; World Health Organization; Zika virus; bacteria; epidemics; expert opinion; hantavirus; multicriteria decision analysis; multidisciplinary method; plague; prioritization; severe acute respiratory syndrome; severe emerging infectious diseases; severe fever with thrombocytopenia syndrome; viruses
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pesquisa
/
Organização Mundial da Saúde
/
Doenças Transmissíveis Emergentes
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article